Stocks and Investing Stocks and Investing
Mon, April 17, 2023

Jasper Hellweg Maintained (BIIB) at Strong Buy with Increased Target to $320 on, Apr 17th, 2023


Published on 2024-10-28 02:47:47 - WOPRAI, Jasper Hellweg
  Print publication without navigation


Jasper Hellweg of Argus Research, Maintained "Biogen Inc." (BIIB) at Strong Buy with Increased Target from $315 to $320 on, Apr 17th, 2023.

Jasper has made no other calls on BIIB in the last 4 months.



There are 8 other peers that have a rating on BIIB. Out of the 8 peers that are also analyzing BIIB, 0 agree with Jasper's Rating of Hold.



These are the ratings of the 8 analyists that currently disagree with Jasper


  • Matthew Korn of "Morgan Stanley" Maintained at Buy with Decreased Target to $349 on, Wednesday, April 12th, 2023
  • Ami Fadia of "Needham" Reiterated at Strong Buy and Held Target at $325 on, Tuesday, April 11th, 2023
  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $325 on, Thursday, March 23rd, 2023
  • Brian Abrahams of "RBC Capital" Maintained at Buy with Decreased Target to $333 on, Thursday, February 16th, 2023
  • Colin Bristow of "UBS" Maintained at Strong Buy with Increased Target to $340 on, Thursday, February 16th, 2023
  • Jay Olson of "Oppenheimer" Maintained at Buy with Decreased Target to $310 on, Thursday, February 16th, 2023
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $351 on, Thursday, February 16th, 2023
  • Phil Nadeau of "Cowen & Co." Maintained at Buy with Increased Target to $315 on, Thursday, February 16th, 2023

Contributing Sources